Clinical Trial Update: Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating human umbilical cord-derived mesenchymal stem cells for hepatic cirrhosis; trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cirrhosis

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD | Conditions: Hepatic Cirrhosis | Phase 1 | Status: UNKNOWN